Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Currents in Pharmacy Teaching & Learning|July 9, 2022
Teaching Spanish using the pharmacists' patient care processSara A Thompson, Taylor Praska
Reports (MDPI)|July 25, 2025
Treatment of Leptomeningeal Disease with Tepotinib in a Patient with Lung Adenocarcinoma Harboring MET Exon 14 Skipping Mutation Presenting with Extensive Metastasis Involving DuodenumJacquelyn Shugarts, Aida Amado, Taylor Praska, et al.
Reports (MDPI)|July 23, 2025
Osimertinib-Induced Hepatitis Following Immunotherapy in a Patient with Lung Adenocarcinoma Harboring De Novo EGFR Exon 19 Deletion and T790M Mutations: A Case ReportBradley Steiner, Amanda Edmond, Monica Camou, et al.
JTO Clinical and Research Reports|April 20, 2026
First Documented Response to Tarlatamab in a Patient With Transformed SCLC Without Actionable Gene Alteration: Case ReportBrandon Poppe, Taylor Praska, Monica Camou, et al.
Innovations in Pharmacy|May 19, 2021
GPAs, PCATs, and Coupons: Wilting Quality in Pharmacy School Admissions and the Impact on Pharmacy FacultySara A Thompson
Behavioral Sciences (Basel, Switzerland)|May 27, 2026
Mindful Attention and Pain Appraisal During Isometric ExerciseSara A Thompson, Sarah Ullrich-French, Anne E Cox
Behavioral Sciences (Basel, Switzerland)|November 27, 2025
The Mindful Reappraisal of Pain Scale: Initial Validity Evidence for Use as a State Measure Following Isometric ExerciseSara A Thompson, Reese Small, Anne E Cox, et al.
Currents in Pharmacy Teaching & Learning|December 15, 2019
Identifying opportunities for PharmD curricular reform by surveying oncology pharmacists about career preparedness and exposureSara A Thompson, Margie E Padilla, Amanda M Loya, et al.
Gynecologic Oncology|April 20, 2010
Ovarian cancer in the elderly: outcomes with neoadjuvant chemotherapy or primary cytoreductionKate A McLean, Chirag A Shah, Sara A Thompson, et al.
The Journal of Clinical Investigation|June 24, 2009
IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)Joanne L Jones, Chia-Ling Phuah, Amanda L Cox, et al.
Pageof 1